# India Porcine Vaccines Market > India Porcine Vaccines Market Research Report: Size, Share, Trend Analysis By Types (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD), Others) and By End-user (Veterinary Hospitals, Hog Production Farm) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.67% - **2024:** $ 96 Million - **2025:** $ 101.44 Million - **2035:** $ 176 Million - **Key Players:** Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Ceva Santé Animale (FR), Vetoquinol (FR), Huvepharma (BG), Phibro Animal Health (US) **Report ID:** MRFR/Pharma/49056-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-porcine-vaccines-market-50813 --- ## Market Summary ## **India Porcine Vaccines Market Overview** As per MRFR analysis, the India Porcine Vaccines Market Size was estimated at 89.5 (USD Million) in 2024. The India Porcine Vaccines Market Industry is expected to grow from 96 (USD Million) in 2025 to 213 (USD Million) by 2035. The India Porcine Vaccines Market CAGR (growth rate) is expected to be around 7.514% during the forecast period (2025 - 2035). The India Porcine Vaccines Market is significantly influenced by a rise in pig farming activities and the increasing consumption of pork among the Indian population. This growing interest in livestock health management is driven by both the need for quality meat products and the rising awareness of animal welfare. The government of India has been implementing measures to promote biosecurity and vaccination programs among farmers, which bolsters the importance of porcine vaccines in disease prevention. Partnerships between agricultural departments and veterinary practitioners are also becoming more common, enhancing the distribution and accessibility of vaccines in rural areas. Opportunities in the market are emerging as demand for efficient and effective vaccines increases. Innovations in vaccine formulations are being explored, which can improve immunity and reduce the incidence of diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS) and swine influenza. The growing trend toward sustainable farming practices presents an additional avenue as farmers seek eco-friendly vaccine options that align with modern agricultural practices. Recent trends indicate a shift towards integrating technology in livestock management, including the use of digital platforms for disease tracking and vaccination records. This technological advancement is affecting how veterinarians and farmers interact, making it easier to monitor pig health. Additionally, there is a rising trend of collaborative efforts among industry stakeholders to address challenges in vaccine distribution logistics, ensuring that vaccines reach farms timely and efficient. Overall, the India Porcine Vaccines Market is evolving with a strong emphasis on health management, technological integration, and sustainable farming practices, positioning itself for future growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **India Porcine Vaccines Market Drivers** ### **Increasing Awareness of Animal Health** There is a growing awareness among pig farmers in India regarding the importance of vaccination in controlling diseases and enhancing productivity. According to the Animal Husbandry Department of the Government of India, there has been a notable increase in vaccination coverage among livestock, with approximately 75% of farmers now vaccinating their animals. This is largely driven by initiatives from organizations such as the Indian Veterinary Association that advocate for disease prevention through preventive healthcare practices. The robust support from governmental programs focused on biosecurity and animal welfare plays a crucial role in fostering this awareness, thus driving the growth of the India Porcine Vaccines Market Industry. ### **Rise in Pork Consumption** Pork has been emerging as a popular source of protein among Indian consumers, leading to increased pig farming. The Food and Agricultural Organization of the United Nations reported that per capita pork consumption in India has risen by approximately 10% over the last five years, indicating a strong consumer demand. This escalating demand for pork necessitates enhanced vaccination protocols to ensure the health and productivity of pigs. Consequently, this trend is positively influencing the growth of the India Porcine Vaccines Market Industry, making vaccines an essential aspect of modern pig farming. ### **Government Initiatives and Support** The Indian government has implemented several initiatives to boost the livestock sector, focusing on improving animal health and productivity. For example, the National Livestock Mission aims to augment livestock production by promoting health care measures for various species, including pigs. These initiatives have significantly influenced farmers' access to vaccines, increasing the adoption rate of immunization practices among pig farmers. This strong governmental backing is critical in driving growth trends in the India Porcine Vaccines Market Industry, as it encourages farmers to invest in vaccination for better yields. ### **Advancements in Vaccine Technology** Innovations and advancements in vaccine technology are facilitating improved efficacy and efficiency in disease management for pig farming. Indian research institutions and universities are increasingly focusing on developing improved vaccines against endemic diseases affecting pigs. For instance, the Indian Council of Agricultural Research has reported progress in designing vaccines tailored to local strains of diseases. Such advancements not only help in controlling disease outbreaks but also lead to decreased mortality rates among pigs, thereby encouraging farmers to prioritize vaccination. This development greatly benefits the animal health technology sector, such as the India Porcine Vaccines Market Industry, for technology is its backbone. ## **India Porcine Vaccines Market Segment Insights** ### **Porcine Vaccines Market Type Insights** The India Porcine Vaccines Market exhibits a diverse range of types that play vital roles in safeguarding swine health and enhancing productivity. The major type categories include Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, and DNA vaccines. Inactivated vaccines are crucial for providing immunity without the risk of causing disease, making them a favored choice among veterinarians. These vaccines are essential in managing endemic diseases in pigs, thereby protecting the health of herds across India. Live attenuated vaccines carry a live but weakened pathogen, which tends to yield strong immune responses, making them effective for preventive measures against various viral infections in swine. Toxoid vaccines offer significant benefits by targeting bacterial toxins rather than the bacteria themselves, thus proving vital in controlling diseases that produce harmful toxins. Recombinant vaccines, on the other hand, utilize biotechnology to create vaccine components, fostering a more efficient immune response and broadening their application in enhancing swine health. Conjugate vaccines are noteworthy as they combine polysaccharides with proteins to enhance immunity, especially in cases where traditional vaccines may be less effective. DNA vaccines are emerging as an innovative technology that leverages genetic material to provoke a protective immune response; their adaptability and potential for rapid development make them an important facet of future vaccine strategies. The overall segmentation of the India Porcine Vaccines Market reveals substantial opportunities for growth as swine farming continues to be a significant sector within the Indian agricultural landscape, where efficiency, health management, and disease prevention are crucial. With advancements in veterinary biotechnology and a growing understanding of swine diseases, the market is likely to witness innovations and a shift towards more specialized vaccines tailored to meet the needs of Indian swine farmers. The increasing focus on livestock health and biosecurity practices drives the demand for these vaccines, as they play a fundamental role in improving the overall productivity and profitability of the pork industry. Understanding these dynamics within the Type segment is vital for stakeholders aiming to navigate the evolving landscape of the India Porcine Vaccines Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Porcine Vaccines Market Disease Indication Insights** The Disease Indication segment within the India [Porcine Vaccines Market](../../../reports/porcine-vaccines-market-7438) is a crucial aspect of the industry, focusing on various infectious diseases affecting swine populations. With the substantial increase in pig farming in India, there has been a growing emphasis on vaccines that target Porcine Epidemic Diarrhea (PED) and Porcine Reproductive and Respiratory Syndrome (PRRS), both of which have significant impacts on herd health and productivity. The prevalence of Swine influenza remains a concern due to its potential to cause severe outbreaks, while Aujeszky's disease (AD) and Porcine Circovirus Associated Disease (PCVAD) also contribute significantly to economic losses among farmers. The increasing awareness of biosecurity measures, coupled with advancements in vaccine technology, is driving the demand for effective solutions in the Porcine market. The market is witnessing a trend toward the development of multi-valent vaccines to combat various pathogens simultaneously, reflecting the evolving needs of the livestock sector. As India strives to enhance its livestock health standards and productivity, addressing these disease indications will play a vital role in securing the future of the country's pork industry. ### **Porcine Vaccines Market End-user Insights** The End-user segment of the India Porcine Vaccines Market plays a critical role in healthcare for swine, with Veterinary Hospitals and Hog Production Farms serving as key players in this landscape. Veterinary Hospitals are essential for administering vaccines and ensuring the health and productivity of pigs, acting as a primary point of contact for both preventive and treatment measures. They contribute significantly to maintaining animal welfare and reducing disease outbreaks, which is crucial in a densely populated country like India, where the demand for pork is rising. On the other hand, Hog Production Farms dominate the industry, forming the backbone of pork supply and focusing on biosecurity and vaccination programs to enhance herd immunity and minimize losses due to diseases. These farms are increasingly adopting advanced vaccination techniques and strategies to improve production efficiency and overall livestock health. The rising focus on antibiotic-free meat production is also driving the demand for effective vaccinal solutions in this segment. The interplay between these End-users significantly influences the market dynamics, highlighting the importance of both Veterinary Hospitals and Hog Production Farms in the overall landscape of the India Porcine Vaccines Market. ## **India Porcine Vaccines Market Key Players and Competitive Insights** The India Porcine Vaccines Market is characterized by a competitive landscape that includes both domestic and international players vying for significant market share. This market is driven by rising awareness about animal health, increased production of pork, and stringent regulations regarding animal vaccination to prevent diseases among porcine populations. The competitive dynamics are shaped by factors like technological advancements in vaccine development, pricing strategies, and strong distribution networks. Understanding the positioning of key players in this market is crucial for identifying trends and forecasting growth opportunities. It is notable that market participants are increasingly focusing on research and development to introduce novel vaccine solutions that address emerging health challenges among pigs. Indian Immunologicals has established a strong foothold in the India Porcine Vaccines Market, primarily through its innovative vaccine formulations and commitment to quality. The company's strengths lie in its production capabilities and extensive distribution network across the country, enabling it to cater to various segments of the market effectively. Indian Immunologicals has a reputation for producing high-quality porcine vaccines that meet both domestic and international standards, thereby gaining the trust of veterinarians and farmers alike. Furthermore, their customer-centric approach and focus on education about the importance of vaccination in swine health contribute to enhancing their market presence. The company’s ability to adapt to changing market needs further solidifies its competitive edge in the Indian landscape. Ceva Animal Health is a prominent player in the India Porcine Vaccines Market, recognized for its comprehensive range of products and services tailored specifically to the needs of the swine industry. The company's key offerings include various vaccines that target prevalent diseases in pigs, supported by their strong research and development initiatives aimed at delivering effective health solutions. Ceva's well-established market presence in India is bolstered by strategic partnerships and collaborations that enhance its distribution capabilities, ensuring that stakeholders have access to essential veterinary products. Their commitment to excellence is reflected in their continuous investment in innovation and technology, which positions Ceva as a leader in providing holistic animal health solutions. The company’s mergers and acquisitions have also expanded its product portfolio and geographical reach, allowing it to better serve the burgeoning porcine sector in India. ### **Key Companies in the India Porcine Vaccines Market Include** - **[Indian Immunologicals](https://www.indimmune.com/wp-content/uploads/pdf/Animal-Health-Vaccines.pdf)** - Ceva Animal Health - Virbac - Neogen Corporation - Heska Corporation - Zoetis - Vetoquinol - Petersime - Biovet - Elanco - Zydus Cadila - Merck Animal Health - Hester Biosciences - Boehringer Ingelheim - Karnataka Veterinary Biologicals Corporation ## **India Porcine Vaccines Market Industry Developments** Recent developments in the India Porcine Vaccines Market have emphasized advancements in disease prevention and control, with several companies active in this space. Indian Immunologicals continues to innovate in porcine health solutions, while Ceva Animal Health and Virbac have introduced new vaccine formulations to combat viral diseases like Porcine Reproductive and Respiratory Syndrome (PRRS). The market is experiencing significant growth due to increasing pig farming and heightened awareness of veterinary health. Notably, Zydus Cadila expanded its portfolio with the launch of new vaccines addressing specific pig diseases in July 2023, further enhancing its market presence. Additionally, the regional demand has prompted companies like Zoetis and Elanco to invest in Research and Development for more effective vaccines. There have been no significant mergers or acquisitions reported in the past few months among key companies like Heska Corporation and Boehringer Ingelheim. The economic valuation of the porcine vaccine sector in India has been positively impacted, driven by a rising trend in livestock vaccination, reinforcing the importance of maintaining animal health standards in the face of growing meat consumption. The Indian government's initiatives to promote livestock health are also influencing market dynamics. ## **India Porcine Vaccines Market Segmentation Insights** ### **Porcine Vaccines Market Type Outlook** - Inactivated vaccines - Live attenuated vaccines - Toxoid vaccines - Recombinant vaccines - Conjugate vaccines - DNA vaccines ### **Porcine Vaccines Market Disease Indication Outlook** - PED (Porcine Epidemic Diarrhea) - PRRS (Porcine Reproductive & Respiratory Syndrome) - Swine influenza - Aujeszky's disease (AD) - Porcine Circovirus Associated Disease (PCVAD) - Others ### **Porcine Vaccines Market End-user Outlook** - Veterinary Hospitals - Hog Production Farm ## Market Drivers ### Emergence of New Vaccines The porcine vaccines market is witnessing innovation with the emergence of new vaccines tailored to combat specific diseases affecting pigs. Research and development efforts are being intensified to create vaccines that are more effective and have fewer side effects. This innovation is crucial as diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS) and Swine Influenza continue to pose threats to pig populations. The introduction of novel vaccines is expected to enhance disease control measures, thereby increasing the overall demand for vaccination. Furthermore, the Indian government is encouraging research initiatives, which may lead to the development of indigenous vaccines, potentially reducing costs and improving accessibility for farmers. This trend indicates a promising future for the porcine vaccines market. ### Increasing Livestock Production The porcine vaccines market in India is experiencing growth due to the increasing demand for livestock production. As the population continues to rise, the need for pork as a protein source is becoming more pronounced. The Indian government has set ambitious targets for livestock production, aiming to enhance food security and improve nutritional standards. This has led to a greater emphasis on animal health, with vaccination being a critical component. The market for porcine vaccines is projected to grow at a CAGR of approximately 8% over the next few years, driven by the necessity to maintain healthy herds and optimize production efficiency. Farmers are increasingly recognizing the importance of vaccination in preventing diseases that can lead to significant economic losses, thereby propelling the porcine vaccines market forward. ### Expansion of Veterinary Services The expansion of veterinary services in India is playing a crucial role in the growth of the porcine vaccines market. With an increasing number of veterinary professionals entering the field, access to veterinary care is improving, particularly in rural areas where pig farming is prevalent. This expansion is accompanied by a rise in the availability of vaccines and related services, making it easier for farmers to vaccinate their livestock. The Indian government has also been investing in veterinary infrastructure, which is expected to enhance the distribution and administration of vaccines. As a result, the porcine vaccines market is likely to benefit from improved service delivery, leading to higher vaccination rates and better overall herd health. ### Rising Awareness of Animal Health There is a notable increase in awareness regarding animal health among farmers and livestock owners in India. This heightened consciousness is largely attributed to educational initiatives and outreach programs aimed at promoting best practices in animal husbandry. As farmers become more informed about the benefits of vaccination, the porcine vaccines market is likely to see a surge in demand. Vaccination is recognized as a vital strategy for disease prevention, which can enhance productivity and profitability. Reports indicate that the adoption rate of vaccines among pig farmers has increased by over 30% in recent years, reflecting a shift towards more proactive health management practices. This trend is expected to continue, further stimulating the growth of the porcine vaccines market. ### Regulatory Support for Vaccination Programs Regulatory support for vaccination programs is a significant driver of the porcine vaccines market in India. The government has implemented various policies aimed at promoting animal health and welfare, which include vaccination initiatives. These programs are designed to mitigate the impact of infectious diseases on livestock, thereby ensuring food safety and security. The establishment of guidelines and standards for vaccine usage is fostering a more structured approach to vaccination among farmers. Additionally, financial incentives and subsidies for vaccine purchases are being offered, making it more feasible for farmers to vaccinate their herds. This regulatory framework is likely to enhance the adoption of vaccines, contributing positively to the growth of the porcine vaccines market. ## Future Outlook The [Porcine Vaccines Market](https://www.marketresearchfuture.com/reports/porcine-vaccines-market-7438) in India is projected to grow at a 5.67% CAGR from 2025 to 2035, driven by increasing livestock health awareness and regulatory support. **New opportunities:** - Development of customized vaccine formulations for regional diseases. - Expansion of digital platforms for vaccine tracking and management. - Partnerships with local farmers for on-site vaccination services. By 2035, the porcine vaccines market is expected to achieve robust growth and enhanced market penetration. ## Segment Insights ### By Type: Inactivated vaccines (Largest) vs. Recombinant vaccines (Fastest-Growing) The market share distribution within the Type segment reflects a diverse landscape in the India porcine vaccines market. Inactivated vaccines hold the largest share, demonstrating their well-established efficacy and safety profile, which appeals to many producers and veterinarians. Following closely are live attenuated vaccines, which also occupy a significant portion of the market, valued for their ability to stimulate a robust immune response. However, recombinant vaccines are emerging as a noteworthy competitor, capturing attention due to their innovative approach and increasing demand for advanced vaccination strategies. The growth trends in this segment are driven by technological advancements and a greater emphasis on animal health management. Inactivated vaccines are favored for their reliability, while recombinant vaccines are experiencing rapid adoption as they offer precision and improved safety. The shift towards more effective vaccine formulations is enhancing the market's adaptability, ultimately fostering a competitive environment that benefits animal health management and producers aiming for enhanced productivity. Inactivated vaccines (Dominant) vs. Recombinant vaccines (Emerging) Inactivated vaccines are characterized by their proven effectiveness in controlling porcine diseases, making them the dominant choice for many producers in the India porcine vaccines market. Their ability to provide stable immunity without the risk of disease transmission reinforces their market position. In contrast, recombinant vaccines, while emerging, are gaining traction due to their modern production techniques that offer specificity and reduced side effects. This innovative approach appeals to a growing segment of producers looking for efficient and tailored vaccination solutions. Both vaccine types highlight the transition towards advanced veterinary care practices aimed at enhancing pig health outcomes and overall farm productivity. ### By Disease Indication: PED (Largest) vs. PRRS (Fastest-Growing) In the India porcine vaccines market, the disease indication segment is prominently led by Porcine Epidemic Diarrhea (PED), which commands the largest market share. Following PED, Porcine Reproductive & Respiratory Syndrome (PRRS) exhibits significant contributions, while other diseases like Swine Influenza, Aujeszky's Disease, and Porcine Circovirus Associated Disease (PCVAD) play supportive roles in overall market dynamics. Collectively, these segments reflect the intricate landscape of porcine health challenges in India. Growth trends indicate that PRRS is rapidly becoming the fastest-growing segment as awareness and preventive measures among livestock farmers increase. The ongoing concerns over livestock health, coupled with rising incidences of these diseases, particularly PED and PRRS, have amplified vaccine demand. Innovations in vaccine formulations and government initiatives for better livestock management further drive growth in this segment, ultimately aiming to ensure the health and productivity of swine herds. PED (Dominant) vs. PRRS (Emerging) Porcine Epidemic Diarrhea (PED) is regarded as the dominant segment in the India porcine vaccines market due to its high prevalence and impact on young pigs, leading to substantial mortality. Farmers and veterinarians prioritize PED vaccines to safeguard against outbreaks, resulting in substantial market commitments. In contrast, Porcine Reproductive & Respiratory Syndrome (PRRS) is emerging as a crucial player, known for its complex respiratory and reproductive issues affecting swine. Increased investments in research and development for effective PRRS vaccines reflect the urgent need to address this disease, presenting opportunities for growth and innovation in vaccine technologies. The focus on PRRS is expected to rise, driven by its growing economic burden on the livestock sector. ### By End-user: Hog Production Farm (Largest) vs. Veterinary Hospitals (Fastest-Growing) In the India porcine vaccines market, Hog Production Farms hold the largest market share due to their extensive reliance on immunization strategies to ensure healthy livestock and optimum production levels. These farms prioritize vaccination programs as central to disease prevention and maintaining herd health, which contributes significantly to their dominance in the market. Veterinary Hospitals, on the other hand, are emerging as a vital segment, catering to a growing number of small to medium-sized farms seeking advanced veterinary care. Their role in providing vaccination services is increasingly recognized, driving their share of the market higher. Growth trends indicate a robust expansion in the Veterinary Hospitals segment, driven by an increase in livestock farming and heightened awareness regarding animal health. The demand for veterinary services is climbing, especially as farmers become more informed about the importance of vaccinations. Factors such as technological advancements in vaccine development and government support for livestock health initiatives are propelling the growth of Veterinary Hospitals, positioning them as the fastest-growing segment within the India porcine vaccines market. Veterinary Hospitals (Dominant) vs. Hog Production Farm (Emerging) Hog Production Farms are characterized by their large-scale operations and focus on optimizing production efficiencies through effective vaccination strategies. This segment often leads the market due to their established immunization protocols and collaboration with veterinary services to ensure the health of the herds. In contrast, Veterinary Hospitals have emerged as a critical player in the sector, particularly with changes in consumer attitudes towards animal welfare and health. These facilities are increasingly tailored to meet the needs of smaller farming operations by providing specialized vaccination programs, thereby enhancing their market relevance and growth potential. Their dual role in treating animals and managing preventative health measures highlights their growing importance in the India porcine vaccines market. ## Competitive Benchmarking The porcine vaccines market in India is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Zoetis (US), Boehringer Ingelheim (DE), and Merck Animal Health (US) are at the forefront, leveraging their extensive research capabilities and established market presence to drive growth. These companies appear to focus on developing advanced vaccine formulations and enhancing their distribution networks, which collectively fosters a dynamic competitive environment. The emphasis on localized production and tailored solutions for Indian farmers indicates a strategic alignment with regional needs, thereby enhancing customer loyalty and market penetration.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach not only mitigates the risks associated with The porcine vaccines market demands. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. Their ability to innovate and adapt to local conditions is crucial in maintaining competitive advantages. In October Zoetis (US) announced the launch of a new vaccine specifically targeting Porcine Reproductive and Respiratory Syndrome (PRRS), a significant disease affecting swine health. This strategic move is likely to enhance Zoetis's portfolio and solidify its position as a leader in the porcine vaccines segment. The introduction of this vaccine is expected to address a critical need in the market, potentially leading to increased adoption among swine producers.Similarly, in September 2025, Boehringer Ingelheim (DE) expanded its partnership with local veterinary clinics to enhance vaccine distribution and education. This initiative appears to be a strategic effort to improve access to vaccines and foster better relationships with farmers. By investing in local partnerships, Boehringer Ingelheim is likely to strengthen its market presence and ensure that its products are readily available to end-users, thereby enhancing customer trust and loyalty. In August Merck Animal Health (US) launched a digital platform aimed at providing farmers with real-time data on vaccine efficacy and herd health management. This digital transformation strategy seems to reflect a broader trend towards integrating technology into animal health management. By offering such tools, Merck is not only enhancing its service offerings but also positioning itself as a forward-thinking leader in the industry, likely appealing to tech-savvy farmers. As of November the competitive trends in the porcine vaccines market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, facilitating knowledge sharing and resource optimization. The shift from price-based competition to a focus on innovation and technology is evident, as companies strive to differentiate themselves through advanced solutions and reliable supply chains. This evolution suggests that future competitive differentiation will hinge on the ability to innovate and adapt to the changing needs of the market. ## Recent News & Developments Recent developments in the India Porcine Vaccines Market have emphasized advancements in disease prevention and control, with several companies active in this space. Indian Immunologicals continues to innovate in porcine health solutions, while Ceva Animal Health and Virbac have introduced new vaccine formulations to combat viral diseases like Porcine Reproductive and Respiratory Syndrome (PRRS). The market is experiencing significant growth due to increasing pig farming and heightened awareness of veterinary health. Notably, Zydus Cadila expanded its portfolio with the launch of new vaccines addressing specific pig diseases in July 2023, further enhancing its market presence. Additionally, the regional demand has prompted companies like Zoetis and Elanco to invest in Research and Development for more effective vaccines. There have been no significant mergers or acquisitions reported in the past few months among key companies like Heska Corporation and Boehringer Ingelheim. The economic valuation of the porcine vaccine sector in India has been positively impacted, driven by a rising trend in livestock vaccination, reinforcing the importance of maintaining animal health standards in the face of growing meat consumption. The Indian government's initiatives to promote livestock health are also influencing market dynamics. ## Report Scope | MARKET SIZE 2024 | 96.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 101.44(USD Million) | | MARKET SIZE 2035 | 176.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.67% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Ceva Santé Animale (FR), Vetoquinol (FR), Huvepharma (BG), Phibro Animal Health (US) | | Segments Covered | Type, Disease Indication, End-user | | Key Market Opportunities | Emerging technologies in vaccine development enhance disease control in the porcine vaccines market. | | Key Market Dynamics | Rising demand for porcine vaccines driven by regulatory changes and increasing awareness of animal health in India. | | Countries Covered | India | ## Frequently Asked Questions **Q: What was the market valuation of the India porcine vaccines market in 2024?** A: The market valuation of the India porcine vaccines market was $96.0 Million in 2024. **Q: What is the projected market valuation for the India porcine vaccines market by 2035?** A: The projected market valuation for the India porcine vaccines market is $176.0 Million by 2035. **Q: What is the expected CAGR for the India porcine vaccines market during the forecast period 2025 - 2035?** A: The expected CAGR for the India porcine vaccines market during the forecast period 2025 - 2035 is 5.67%. **Q: Which type of vaccine segment had the highest valuation in 2024?** A: In 2024, the Hog Production Farm segment had the highest valuation at $66.0 Million. **Q: What are the key players in the India porcine vaccines market?** A: Key players in the India porcine vaccines market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, and Ceva Santé Animale. **Q: What was the valuation range for inactivated vaccines in 2024?** A: The valuation range for inactivated vaccines in 2024 was between $30.0 Million and $54.0 Million. **Q: Which disease indication segment is projected to grow the most by 2035?** A: The Porcine Circovirus Associated Disease (PCVAD) segment is projected to grow the most by 2035, with a valuation range of $15.0 Million to $30.0 Million. **Q: What is the valuation range for live attenuated vaccines in 2024?** A: The valuation range for live attenuated vaccines in 2024 was between $25.0 Million and $45.0 Million. **Q: How does the valuation of veterinary hospitals compare to hog production farms in 2024?** A: In 2024, the valuation for veterinary hospitals was $30.0 Million, significantly lower than the $66.0 Million for hog production farms. **Q: What is the projected valuation for recombinant vaccines by 2035?** A: The projected valuation for recombinant vaccines by 2035 is expected to range from $10.0 Million to $20.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-porcine-vaccines-market-50813*